Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
1.960
-0.040 (-2.00%)
At close: Mar 12, 2026, 4:00 PM EDT
1.950
-0.010 (-0.51%)
After-hours: Mar 12, 2026, 7:58 PM EDT
Genprex Market Cap
Genprex has a market cap or net worth of $4.55 million as of March 12, 2026. Its market cap has increased by 45.24% in one year.
Market Cap
4.55M
Enterprise Value
3.28M
1-Year Change
45.24%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $61.25M to $4.55M, a decrease of -92.58%. That is a compound annual growth rate of -27.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 4.64M | 14.29% |
| Dec 31, 2025 | 4.06M | -43.99% |
| Dec 31, 2024 | 7.25M | -47.00% |
| Dec 29, 2023 | 13.67M | -80.37% |
| Dec 30, 2022 | 69.63M | 11.19% |
| Dec 31, 2021 | 62.63M | -64.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptevo Therapeutics | 5.19M |
| MetaVia | 5.07M |
| GeoVax Labs | 5.07M |
| VivoSim Labs | 5.01M |
| Revelation Biosciences | 4.89M |
| Bio Green Med Solution | 4.61M |
| Decoy Therapeutics | 4.59M |
| Lunai Bioworks | 4.57M |